Osteopontin levels in maternal serum and placenta: Associations with fetal growth restriction and neonatal outcomes

In pregnancies complicated by FGR, osteopontin levels were significantly reduced in both maternal serum and placental tissue. This decrease may reflect impaired spiral artery remodeling and placental angiogenesis, contributing to the molecular mechanisms of placental insufficiency and adverse neonatal outcomes.